Signos review
- Grade
- CCaveat
- Month to month
- $199/mo
- GLP-1 with CGM
- Later price
- Not published
- the plan price sits behind an email wall seven steps into the survey
- FDA warning letter
- None found
- checked
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
Signos prices its glucose-monitor program at $225 a month for one month, $150 for three and $127 for six. Its GLP-1 plan gets one number: from $199.
Signos prices the sensor three ways by term and the medication plan once, as a floor. The signup stops at 73% to verify an email address before it will show a plan.
- Advertised $199, no ongoing price published
- Coverage not verified
The verdict
Two products, two standards. The monitor gets a real ladder; the medication plan gets a floor and an intake you cannot finish without handing over an email.
Quick facts
Key facts
- Monitor plan, one month
- $225 a month
- Monitor plan, three months
- $150 a month
- Monitor plan, six months
- $127 a month, auto-renewing
- GLP-1 plan
- From $199 a month, on a three- or six-month term
- Is medication included in that?
- Yes, the page says so — but the plan price is not shown
- Pharmacies named
- Four, with street addresses and phone numbers
- States served
- All fifty and Washington DC, stated in the terms
- Refunds on the monitor
- All sales final, printed under the buy button
Pros and cons
What we like
- The monitor plans show the monthly rate and the rate it is discounted from side by side, at all three terms, on one screen.
- The six-month plan states that it auto-renews every six months and ships in three-month bundles, rather than leaving that to the terms.
- The terms name four dispensing pharmacies by company, street address and phone, and name the clinical contractor that employs the prescribers.
- The terms state the medication plans cover all fifty states plus Washington DC, and the intake's own state menu matches that.
What could be better
- The GLP-1 plan has one published figure, worded as a floor, with no ladder and no stated month-to-month option.
- Seven steps of intake produced no price at all; the survey stops at 73% to verify an email address first.
- All sales final, no refunds or exchanges, sits under the monitor buy button — and the monitor is the cheaper half of what Signos sells.
- No mailing address for the company appears on any of the four legal pages we read, which is the detail that would let anyone check who they are contracting with.
What it is
A continuous glucose monitor with an app that reads your food against your glucose, sold on its own or bundled with a prescription. The bundled version pairs the sensor with a compounded GLP-1 rather than a branded pen, prescribed by clinicians who contract with Signos rather than work for it.
Signos is emphatic that it does not practice medicine, does not compound and does not dispense. Its terms name the clinical contractor and four dispensing pharmacies by company, street address and phone — genuinely more supply-chain detail than most of this market publishes.
Every price we found at Signos
| Plan | Advertised | What you actually pay | The gap |
|---|---|---|---|
| One-month monitor planA month. Two sensors a month. Medication is not part of this plan. | $299 | $225 | |
| Three-month monitor planA month across a three-month term. | $199 | $150 | |
| Six-month monitor planA month across six months, auto-renewing every six months, shipped in three-month bundles. | $169 | $127 | |
| GLP-1 plan with monitorStarting at, a month, on a three- or six-month treatment plan. Medication and sensors included. No other figure is published, and the intake will not show one without a verified email. | not published | $199 | not comparable |
What it actually costs at Signos
The monitor side is priced properly: $225 a month for one month, $150 for three, $127 for six, each shown beside the rate it is discounted from, with the six-month plan's auto-renewal stated. Measured prices its two structures the same clear way.
Switch the same page to the GLP-1 plan and the ladder vanishes. One figure, $199 a month, prefixed starting at, on a plan described only as three or six months — a floor with no ceiling.
We went through the GLP-1 survey seven steps: date of birth, sex, state, height, weight, goal, medication history, health conditions, pregnancy, drug preference. No price appeared. At 73% it stops and asks for an email it then declines to accept unless it verifies. That is how we check a price is truly unpublished. Ways2Well puts its peptide prices behind a paid consult and a verification wall.
Who it's wrong for
- Skip it if you want to know the medication price before handing over contact details. You cannot reach it without them.
- Skip it if you want a month of the medication plan. The only terms named are three and six months.
- Skip it if you are already on a GLP-1 and only want the sensor — that is a different product here, and the page routes you to a part-time program with the medication removed.
- You chose it for the named pharmacies: Care Bare Rx names four with addresses, and its prescribers with NPI numbers.
- Want a GLP-1 plan with the medication included and a published recurring rate: Noom Med prints the first-month and the recurring figure in the same row.
How Signos works
Take the two-minute survey
Date of birth, state, height and weight, goal, medication history and health conditions. The state menu lists all fifty plus Washington DC.
Hand over an email to see a plan
At 73% the survey stops and asks for an address it verifies before continuing. No price is shown before this point.
A contracted clinician decides
Prescribers work for the clinical contractor named in the terms, not for Signos, and can decline to prescribe.
Medications available
- Compounded semaglutideCompoundedInside the GLP-1 plan, from $199 a month
Offered as a preference in the intake. Compounded in a 503A pharmacy, per the survey's own disclosure.
- Compounded tirzepatideCompoundedInside the GLP-1 plan, from $199 a month
The second option in the same choice. The survey does not price the two differently at any point we reached.
Is Signos legit?
Signos is operated by Signos, Inc., according to its terms and conditions.
No FDA warning letters found — checked
Pharmacy, prescribers and safety checks
- Pharmacies namedFour, by company, street address and phone, in the terms
- Who prescribesClinicians contracted through OpenLoop Health, named in the terms as independent of Signos
- Compounding disclosureStated twice: compounded medications are produced in FDA-registered facilities but are not FDA approved
- States servedAll fifty and Washington DC, per the terms
- RefundsAll sales final on the monitor plans; medication refunds are limited to the most recent cycle
- Mailing addressNot disclosed on any legal page we read
Common questions
How much does Signos cost a month?
The monitor program is $225 a month for one month, $150 for three and $127 for six. The plan that adds a GLP-1 prescription is published only as from $199 a month.
Does the Signos GLP-1 plan include the medication?
The page says medication and sensors are both included in the plan price. What it does not publish is what that plan actually costs at either of its two terms.
Can I buy a single month of the GLP-1 plan?
Nothing on the page offers one. The plan is described as a three- or six-month treatment plan, and no month-to-month rate is published for it anywhere.
Which pharmacies fill a Signos prescription?
The terms name four by company, street address and phone number, and say the clinical contractor holds the pharmacy relationships rather than Signos itself.
Which states does Signos serve?
The terms state the medication plans are offered in all fifty states plus Washington DC, and the intake's own state menu matches that list exactly.
Can I get a refund from Signos?
Not on the monitor plans, which print all sales final under the buy button. Medication refunds are limited to the most recent billing cycle.
Why we gave Signos a C
Read the full grading rationale
Signos prices its two products to two different standards. The glucose-monitor program gets a real ladder, $225 a month for one month, $150 for three, $127 for six, with auto-renewal stated. The GLP-1 plan gets one figure, starting at $199 a month, and the signup stops behind an email check before any plan price appears. What it publishes well is its supply chain: the clinical provider, four named pharmacies, and all fifty states plus Washington DC.
Read the evidence
How we reviewed Signos
We read the plans page in both of its views, the monitor plan and the GLP-1 plan, which show behind a toggle one at a time.
We went through the GLP-1 signup seven steps, until it stopped to ask for an email address, without paying.
Where each price comes from
- Plans page
SAVE 25% PER MONTH 6-MONTH CGM PLAN Ideal for long-term results $127 /MONTH $169
- Plans page
STARTING AT SIGNOS+ PLAN Clinician-prescribed GLP-1 + CGM $199 /MONTH
Alternatives to Signos
| Provider | Grade | Published price context |
|---|---|---|
| Andrew Meds | BMinor gap | From $199/mo for semaglutide |
| Ascend Vitality | CCaveat | From $199/mo for semaglutide |
| BloomWell Rx | CCaveat | From $199/mo for semaglutide |
| Breeze Meds | FPrice unclear | Monthly medication total not confirmed — publishes $80 for phone or video consultation fee, charged only if you decline treatment |
| Care Bare Rx | BMinor gap | From $199/mo for tirzepatide |